Biopharmaceutical company Quantum Genomics has signed an exclusive license and production agreement with Julphar to market and manufacture firibastat.
06 Dec 2021
01 Oct 2021
Merck (MSD) has agreed to acquire all the outstanding shares of Acceleron Pharma for $11.5bn in cash.
11 Feb 2021
Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine manufacturing capability.